- TLDR Biotech
- Posts
- Biotech & Pharma Updates | July 22 - 23, 2024
Biotech & Pharma Updates | July 22 - 23, 2024
Pfizer and Beigene open new facilities, Novo Nordisk buys 200 acres of land, Third Arc launches with $165M, Merck & Co. claim infant RSV win (but no data yet), and sinking generic prices might be exacerbating US drug shortages
All the top Biotech & Pharma news in one daily newsletter.
What to understand how these updates are formatted? Check-out the FAQ.
Have any feedback? I’d love to hear from you!📣
(You can also reach out to me on LinkedIn)
Last thing - if you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️
⬇️ The Good News ⬇️
THE GOOD
Business Development
SCYNEXIS hits clinical milestone, triggers $10M payment from GSK
Small molecule, antifungal - Read more
AstraZeneca in-licenses Pinetree Therapeutics preclinical asset for $45M upfront, $500M biobucks
Small molecule, cancer - Read more
THE GOOD
Clinical Trials
ViiV Healthcare’s (GSK HIV unit) two-drug HIV regimen bests Gilead Sciences’ three-drug regimen in head-to-head trial
Small molecule, antiretroviral, HIV infection, postmarketing clinical trial - Read more
Merck & Co. claims win in Ph2b/3 trial for preventing infant RSV infection, but doesn’t (yet) provide receipts
Monoclonal antibody, respiratory syncytial virus - Read more
Cytoki Pharma showcases positive Ph1 data for obesity med CK-0045
Protein, obesity, weight loss - Read more
Cellectar Biosciences touts positive pivotal study data
Radiopharma, Waldenstrom’s Macroglobulinemia, cancer - Read more
Zymeworks lands FDA IND clearance for antibody-drug conjugate
Antibody-drug conjugate, ovarian cancer, gynecological cancers - Read more
THE GOOD
Company Launches
Third Arc Bio launches with $165M
Antibody, T cell engaging, cancer, autoimmune - Read more
Abiologics emerges from stealth with $50M from Flagship Pioneering
Nonstandard amino acids, oncology, cancer, immunology - Read more
THE GOOD
Earnings & Finances
IQVIA reports better-than-expected Q2 performance
CRO, clinical research services - Read more
THE GOOD
Fundraises
Brenig Therapeutics $65M Series A
Small molecule, Parkinson’s Disease, AI/ML - Read more
Telix Pharmaceuticals $398M raise via convertible bonds
Radiopharma, diagnostic imaging agents, kidney cancer, brain cancer - Read more
Windtree Therapeutics $12.9M financing via private placement of Series C preferred stock
Small molecule, acute heart failure, cardiogenic shock, cancer - Read more
Magenta Medical $105M raise
Miniaturized blood pumps, percutaneous coronary interventions, medical device - Read more
THE GOOD
Investments
Pfizer cuts ribbon on $743M Singapore API plant expansion
Small molecule, antibiotics, cancer, pain management, manufacturing - Read more
BeiGene opens $800M US clinical R&D site
Research & development, cancer - Read more
Novo Nordisk buys 200 acres of land in Denmark, potential new production site
GLP-1, manufacturing - Read more
THE GOOD
Partnerships
Eyenovia, Senju Pharmaceutical partner on chronic eye disease NDA
Small molecule, chronic eye disease - Read more
Mendus, Institut Bergonié clinical trial collab on soft tissue sarcoma combo therapy
Allogeneic dendritic cell therapy, soft tissue sarcoma, combo therapy, cancer - Read more
THE GOOD
Product Launches
Insilico Medicine launches medical manuscript writer AI-helper
Medical research writing, AI assistant - Read more
THE GOOD
Strategic Plans
MyMD Pharmaceuticals rebrands to TNF Pharmaceuticals
Small molecule, anti-aging, inflammation - Read more
ENJOYING THESE NEWSLETTERS?
Consider an optional paid subscription.
It’s a lot of work to put together a daily newsletter, and it’s currently just me writing these things (+ one part-time contractor - no fancy editing team!).
If you’re getting value out of these daily compilations, please consider a paid subscription (only $5/month) to support my continued work on this project.
⬇️ The Bad News ⬇️
THE BAD
Clinical Trials
Jaguar Health anti-diarrhea med slips in Ph3, misses endpoint
Small molecule polymer, cancer or chemotherapy induced diarrhoea - Read more
THE BAD
Lawsuits
AbbVie files 340B contract pharmacy suit in Missouri
340B contract pharmacy, compounding - Read more [Paywall]
⬇️ The Ugly News ⬇️
THE UGLY
Politics & Policy
House Committee on Oversight and Accountability releases final version of scathing PBM report
Pharmacy benefit manager, drug pricing - Read more
THE UGLY
Shortages
Why so many US drug shortages? One report blames sinking generic drug prices
Generics, drug pricing - Read more
THE UGLY
Withdrawals & Recalls
Hikma Pharmaceuticals recalls acetaminophen injections over bad labelling issue
Small molecule, pain management, labelling - Read more
Brassica Pharma faked results, and a host of other issues, according to FDA warning letter
CDMO, sterile manufacturing - Read more [Paywall]
You’re all caught up on the latest Pharma & Biotech News!
Gif: charligurl on Giphy
TLDR Biotech wants to hear from you! 📣
Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝
Want to sponsor this newsletter and reach an audience of 600+ biotech and pharma professionals? Reach us here. 👍
Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here.